On the Management of Lot Release of Biological Products in China under the Comparative Analysis of Four Editions of Management of Lot Release of Biological Products

Zhang Weimin, Huang Baobin, Cheng Shuanghong

Chinese Pharmaceutical Affairs ›› 2021, Vol. 35 ›› Issue (6) : 607-613.

Chinese Pharmaceutical Affairs ›› 2021, Vol. 35 ›› Issue (6) : 607-613. DOI: 10.16153/j.1002-7777.2021.06.001
Supervision Administration

On the Management of Lot Release of Biological Products in China under the Comparative Analysis of Four Editions of Management of Lot Release of Biological Products

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2021, 35(6): 607-613 https://doi.org/10.16153/j.1002-7777.2021.06.001

References

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}

Accesses

Citation

Detail

Sections
Recommended

/